
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase
Klemens Hoegenauer, Shaojian An, Jake Axford, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1631-1639
Closed Access | Times Cited: 16
Klemens Hoegenauer, Shaojian An, Jake Axford, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1631-1639
Closed Access | Times Cited: 16
Showing 16 citing articles:
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 95
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 95
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
Panrui Lu, Y. Cheng, Lei Xue, et al.
Cell (2024)
Closed Access | Times Cited: 14
Panrui Lu, Y. Cheng, Lei Xue, et al.
Cell (2024)
Closed Access | Times Cited: 14
Emerging strategies for prospective discovery of molecular glue degraders
Baiyun Wang, Shiyun Cao, Ning Zheng
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102811-102811
Closed Access | Times Cited: 8
Baiyun Wang, Shiyun Cao, Ning Zheng
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102811-102811
Closed Access | Times Cited: 8
Degron tagging for rapid protein degradation in mice
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
The B30.2/SPRY-Domain: A Versatile Binding Scaffold in Supramolecular Assemblies of Eukaryotes
Peer R. E. Mittl, Hans‐Dietmar Beer
Crystals (2025) Vol. 15, Iss. 3, pp. 281-281
Open Access
Peer R. E. Mittl, Hans‐Dietmar Beer
Crystals (2025) Vol. 15, Iss. 3, pp. 281-281
Open Access
Chemically Induced Nuclear Pore Complex Protein Degradation via TRIM21
Xiaomei Li, Qingyang Wang, Anping Guo, et al.
ACS Chemical Biology (2025)
Closed Access
Xiaomei Li, Qingyang Wang, Anping Guo, et al.
ACS Chemical Biology (2025)
Closed Access
Development of Ligands and Degraders Targeting MAGE-A3
Ke Li, Mackenzie W. Krone, Arseniy Butrin, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 36, pp. 24884-24891
Closed Access | Times Cited: 3
Ke Li, Mackenzie W. Krone, Arseniy Butrin, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 36, pp. 24884-24891
Closed Access | Times Cited: 3
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Drug Discovery Approaches to Target E3 Ligases
A. Rodríguez-Gimeno, Carles Galdeano
ChemBioChem (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
A. Rodríguez-Gimeno, Carles Galdeano
ChemBioChem (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7
Christian J. Muñoz Sosa, Christopher Lenz, Anton Hamann, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1638-1647
Closed Access | Times Cited: 1
Christian J. Muñoz Sosa, Christopher Lenz, Anton Hamann, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1638-1647
Closed Access | Times Cited: 1
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Selective degradation of multimeric proteins via chemically induced proximity to TRIM21
Panrui Lu, Y. Cheng, Lei Xue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Panrui Lu, Y. Cheng, Lei Xue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A long march for targeted protein degradation in the new era: expanding E3 ligases
Dazhao Mi, A.D. Huang, Song Jingfeng, et al.
Future Medicinal Chemistry (2024), pp. 1-3
Open Access
Dazhao Mi, A.D. Huang, Song Jingfeng, et al.
Future Medicinal Chemistry (2024), pp. 1-3
Open Access
Fragment-based approaches to discover ligands for tumor-specific E3 ligases
Junhyeong Yim, S S Kim, Hyung Ho Lee, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-14
Closed Access
Junhyeong Yim, S S Kim, Hyung Ho Lee, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-14
Closed Access
Redirecting E3 Ubiquitin Ligases for Targeted Protein Degradation with Heterologous Recognition Domains
Huan Yang, Ge Zheng, Grace Y. Li, et al.
Journal of Biological Chemistry (2024), pp. 108077-108077
Open Access
Huan Yang, Ge Zheng, Grace Y. Li, et al.
Journal of Biological Chemistry (2024), pp. 108077-108077
Open Access
TRIM for Tissue Specificity
M.D. Hartmann
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 4-5
Open Access
M.D. Hartmann
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 4-5
Open Access